Buchumschlag

Correction to “Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production”

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment
von: Takuya Ataka, et al.
Veröffentlicht: (2024)

Modeling amyloid plaque turnover dynamics improves characterization of drug effects
von: Eline van Maanen, et al.
Veröffentlicht: (2025)

Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia
von: Kenichiro Sato, et al.
Veröffentlicht: (2025)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
von: Ronald C. Petersen, et al.
Veröffentlicht: (2025)

Estimating the optimal cutoff for the IGT‐AD Distress subscale adapted for amyloid PET results disclosure
von: Dianxu Ren, et al.
Veröffentlicht: (2025)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
von: Linda J. Van Eldik, et al.
Veröffentlicht: (2024)

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual‐level data from the A4 study of solanezumab
von: Sarah F. Ackley, et al.
Veröffentlicht: (2026)

Mapping sex differences in brain and cognition in relation to APOE ε4 and amyloid burden: A longitudinal normative modelling study
von: Sivaniya Subramaniapillai, et al.
Veröffentlicht: (2026)

Clinical efficacy of anti‐amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 results
von: Stefan Teipel, et al.
Veröffentlicht: (2025)

Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
von: Xiaojuan Li, et al.
Veröffentlicht: (2025)

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging
von: Akira Sekikawa, et al.
Veröffentlicht: (2025)

Association of Excessive Daytime Sleepiness With Long‐Term Incident Dementia: The Role of β‐Amyloid and White Matter Injury
von: Xiaowen Zhou, et al.
Veröffentlicht: (2026)

Commentary on Greenberg et al., “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” [ Alzheimer's Dement . 2023; 9(4):e12426. doi.org/10.1002/trc2.12426]
von: Carl V. Hill, et al.
Veröffentlicht: (2024)

Association of region‐specific hippocampal reduction of neurogranin with inflammasome proteins in post mortem brains of Alzheimer's disease
von: Regina T. Vontell, et al.
Veröffentlicht: (2024)

Amyloid: An evolutionarily conserved protein to fight infection or a toxic protein that causes Alzheimer's disease?
von: Jahnavi Shriram, et al.
Veröffentlicht: (2026)

Correction to “Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study”
Veröffentlicht: (2026)

Predicting regional tau accumulation with machine learning‐based tau‐PET and advanced radiomics
von: Saima Rathore, et al.
Veröffentlicht: (2024)

Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative
von: Pranitha Y. Premnath, et al.
Veröffentlicht: (2024)

The association of cholesterol levels with memory and memory change over a 14‐year period in a US national cohort
von: Silvia Miramontes, et al.
Veröffentlicht: (2025)

Cost‐effectiveness of a multicomponent intervention against cognitive decline
von: Christian Brettschneider, et al.
Veröffentlicht: (2025)

Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease
von: Maria L. Faquetti, et al.
Veröffentlicht: (2024)

Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
von: Alan Cronemberger Andrade, et al.
Veröffentlicht: (2025)

Uncovering barriers to early diagnosis of Alzheimer's disease: a European perspective
von: David A. Pérez‐Martínez, et al.
Veröffentlicht: (2025)

Dynamic neurocognitive adaptation in aging: Development and validation of a new scale
von: Filippo Cieri, et al.
Veröffentlicht: (2025)

Dementia severity at incident diagnosis in a population representative sample of older Americans
von: Shengjia Xu, et al.
Veröffentlicht: (2024)

Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease
von: Victoria L. Fleming, et al.
Veröffentlicht: (2025)

Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
von: Krista Lanctot, et al.
Veröffentlicht: (2025)

Promotores program to increase Hispanic/Latino(a) participation in Alzheimer's disease research
von: Zvinka Z. Zlatar, et al.
Veröffentlicht: (2026)

Impact of study partner replacement in a mild cognitive impairment clinical trial
von: Lucy A. Dolmadjian, et al.
Veröffentlicht: (2025)

Recruitment and eligibility in a Phase 1 early Alzheimer's disease trial of Sabirnetug
von: Robyn Moxon, et al.
Veröffentlicht: (2025)

The utility of a composite endpoint for tracking disease progression in Lewy body dementia
von: Elie Matar, et al.
Veröffentlicht: (2026)

Study of the utility and impact of a plasma p‐tau181 Alzheimer's biomarker (SUITABLE)
von: Kyra O'Brien, et al.
Veröffentlicht: (2026)

Hearing loss and cognitive decline: Prioritizing equity in a world in which hearing health matters
von: Carrie L. Nieman, et al.
Veröffentlicht: (2024)

Mitochondrial blood‐based biomarker is related to cardiorespiratory fitness and aging in a sex‐dependent manner
von: Riley E. Kemna, et al.
Veröffentlicht: (2025)

Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist
von: Mona Darwish, et al.
Veröffentlicht: (2026)

From companionship to science: the importance of dogs in advancing translational research on Alzheimer's disease – a scoping review
von: Heloísa Máximo Ribeiro, et al.
Veröffentlicht: (2026)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
von: Zhigang Xie, et al.
Veröffentlicht: (2026)

Developing the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program
von: Sara Moukarzel, et al.
Veröffentlicht: (2024)

Sex differences in Alzheimer's disease blood biomarkers in a Caribbean population of African ancestry: The Tobago Health Study
von: Caterina Rosano, et al.
Veröffentlicht: (2024)

Weight loss and metabolic improvements dominate the microbiome response in the MIND diet intervention: a randomized controlled trial
von: Robin M. Voigt, et al.
Veröffentlicht: (2026)